The management of refractory idiopathic epilepsies (Q34345026)

1 August 2017

1 reference

title

The management of refractory idiopathic epilepsies (English)

1 reference

1 August 2017

E Perucca

1

1 reference

1 August 2017

publication date

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

42 Suppl 3

1 reference

1 August 2017

page(s)

31-35

1 reference

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Antiepileptic drug-induced worsening of seizures in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Atypical evolutions of benign localization-related epilepsies in children: are they predictable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

The benign occipital epilepsies of childhood: an overview of the idiopathic syndromes and of the relationship to migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Benign epilepsy of childhood with centrotemporal spikes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Prognosis of Benign Childhood Epilepsy with Centrotemporal Spikes: A Foliow-Up Study of 168 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Antiepileptic Properties of Clobazam, a 1–5 Benzodiazepine, in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Treatment of "benign" partial epilepsies of childhood, including atypical forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Lamictal (lamotrigine) monotherapy for typical absence seizures in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Lamotrigine for generalised epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Lamotrigine in absence and primary generalized epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Antiepileptic drugs as a cause of worsening seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Juvenile myoclonic epilepsy: factors of error involved in the diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Juvenile myoclonic epilepsy: a 5-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Autosomal dominant nocturnal frontal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

Double-Blind, Placebo-Controlled, Lamotrigine in Treatment-Resistant Generalised Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042SUPPL.3031.X

10.1046/J.1528-1157.2001.042SUPPL.3031.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference